Review
BibTex RIS Cite

Year 2021, Volume: 24 Issue: 1, 96 - 104, 24.02.2021

Merve Candan

https://doi.org/10.7126/cumudj.825256

Abstract

References

  • Hoen B, Duval X, Durack DT. Prevention of Infective endocarditis, In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Disease, 9th Edition. Philadelphia: Elsevier; 2019:1141-1150.
  • Ramsdale D, Turner-Stokes L, Committee Advisory. Prophylaxis and treatment of infective endocarditis in adults: A concise guide. Clin Med J R Coll Physicians. 2004;4:545-550.
  • Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB, et al. Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association. Circulation. 2015;132:1487-1515.
  • Jones TD, Baumgartner L, Bellows MT, Breese BB, Kuttner AG, McCarty M, Rammelkamp CH. Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis, American Heart Association. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation. 1955;11:317-320.
  • Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis(new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology(ESC).Endorsed by the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) and the International Society of Chemotherapy(ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-2413.
  • Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-3128.
  • Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the AHA: a guideline from the AHA Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736-1754.
  • Richey R, Wray D, Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008;336:770-771.
  • Lockhart PB, Blizzard J, Maslow AL, Brennan MT, Sasser H, Carew J. Drug cost implications for antibiotic prophylaxis for dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:345-353.
  • Keller K, von Bardeleben RS, Ostad MA, Hobohm L, Munzel T, Konstantinides S, et al. Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014. Am J Cardiol. 2017;119:317-322.
  • Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070-2076.
  • Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet Lond Engl. 2015;385:1219-1228.
  • Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob Heart. 2014;9:131-143.
  • Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368:1425-1433.
  • Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463-473.
  • Şimşek-Yavuz S, Akar AR, Aydoğdu S, Berzeg Deniz D, Demir H, Hazırolan T, et al. Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019. 2020;48:187-226.
  • Cahill TJ, Prendergast BD. Infective endocarditis. Lancet Lond Engl. 2016;387:882-893.
  • Nomura R, Naka S, Nemoto H, Inagaki S, Taniguchi K, Ooshima T, et al. Potential involvement of collagen-binding proteins of Streptococcus mutans in infective endocarditis. Oral Dis. 2013;19:387-393.
  • Barot H, Alsindi F. Endocarditis. Hosp Med Clin. 2017;6:229-243.
  • Serap Şimşek-Yavuz. İnfektif Endokardit: Güncel Bilgiler. Klimik J. 2015;28.
  • Bikdeli B, Wang Y, Kim N, Desai MM, Quagliarello V, Krumholz HM. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62:2217-2226.
  • DeSimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, et al. Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. Am Heart J. 2015;170:830-836.
  • Duval X, Delahaye F, Alla F, Tattevin P, Obadia J-F, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59:1968-1976.
  • Mackie AS, Liu W, Savu A, Marelli AJ, Kaul P. Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines. Can J Cardiol. 2016;32:942-948.
  • Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA. 2017;317:1652-1660.
  • van den Brink FS, Swaans MJ, Hoogendijk MG, Alipour A, Kelder JC, Jaarsma W, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands. Eur Heart J Qual Care Clin Outcomes. 2017;3:141-147.
  • Thornhill MH, Gibson TB, Cutler E, Dayer MJ, Chu VH, Lockhart PB, et al. Antibiotic Prophylaxis and Incidence of Endocarditis Before and After the 2007 AHA Recommendations. J Am Coll Cardiol. 2018;72:2443-2454.
  • Recommendations for research | Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | Guidance | NICE. Available from: https://www.nice.org.uk/guidance/cg64/chapter/recommendations-for-research.
  • Sakai Bizmark R, Chang R-KR, Tsugawa Y, Zangwill KM, Kawachi I. Impact of AHA’s 2007 guideline change on incidence of infective endocarditis in infants and children. Am Heart J. 2017;189:110-119.
  • Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS, et al. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J. 2012;163:894-899.
  • Bates KE, Hall M, Shah SS, Hill KD, Pasquali SK. Trends in infective endocarditis hospitalisations at United States children’s hospitals from 2003 to 2014: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Cardiol Young. 2017;27:686-690.
  • DeSimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, et al. Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association’s Prevention Guidelines: An Extended Evaluation of the Olmsted County, Minnesota, Population and Nationwide Inpatient Sample. Mayo Clin Proc. 2015;90:874-881.
  • Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67-84.
  • Zegri-Reiriz I, de Alarcón A, Muñoz P, Martínez Sellés M, González-Ramallo V, Miro JM, et al. Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse. J Am Coll Cardiol. 2018;71:2731-2740.
  • Dayer M, Thornhill M. Is antibiotic prophylaxis to prevent infective endocarditis worthwhile? J Infect Chemother Off J Jpn Soc Chemother. 2018;24:18-24.
  • Franklin M, Wailoo A, Dayer MJ, Jones S, Prendergast B, Baddour LM, et al. The cost-effectiveness of antibiotic prophylaxis for patients at risk of infective endocarditis. Circulation. 2016;134:1568-1578.
  • Guideline on Dental Management of Pediatric Patients Receiving Chemotherapy, Hematopoietic Cell Transplantation, and/or Radiation Therapy. Pediatr Dent. 2016;38:334-342.
  • Squire JD, Gardner PJ, Moutsopoulos NM, Leiding JW. Antibiotic Prophylaxis for Dental Treatment in Patients with Immunodeficiency. J Allergy Clin Immunol Pract. 2019;7:819-823.
  • Thornhill MH, Dayer M, Lockhart PB, Prendergast B. Antibiotic Prophylaxis of Infective Endocarditis. Curr Infect Dis Rep. 2017;19:9.

Infective Endocarditis Prophylaxis in Dentistry: Current Perspective

Year 2021, Volume: 24 Issue: 1, 96 - 104, 24.02.2021

Merve Candan

https://doi.org/10.7126/cumudj.825256

Abstract

Infective endocarditis (IE) is a important heart disease with high morbidity and mortality. Current guidelines suggest antibiotic prohylaxis (AP) to individuals having high risk of IE. These include patients with background of IE, biological or a mechanical prosthetic valve, or a surgically constructed systemic or pulmonary conduit or shunt. The restriction of AP is due to concerns about increased comprehension regarding daily incidence of bacteraemia and antibiotic resistance. Many researchers have examined the effect of restricting AP on the incidence of IE and found different results. Since these studies are mostly observational, they could not establish a causal link between the limitation of AP and the change in the incidence of IE. The purpose of this review is to evaluate the studies evolving the incidence change of IE after the guideline revisions from year of 2007. And dental professionals should periodically visit ADA, AHA and ACC guidelines for updates on AP.

Keywords

Infective endocarditis Antibiotic prophylaxis Dentistry

References

  • Hoen B, Duval X, Durack DT. Prevention of Infective endocarditis, In: Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Disease, 9th Edition. Philadelphia: Elsevier; 2019:1141-1150.
  • Ramsdale D, Turner-Stokes L, Committee Advisory. Prophylaxis and treatment of infective endocarditis in adults: A concise guide. Clin Med J R Coll Physicians. 2004;4:545-550.
  • Baltimore RS, Gewitz M, Baddour LM, Beerman LB, Jackson MA, Lockhart PB, et al. Infective Endocarditis in Childhood: 2015 Update: A Scientific Statement From the American Heart Association. Circulation. 2015;132:1487-1515.
  • Jones TD, Baumgartner L, Bellows MT, Breese BB, Kuttner AG, McCarty M, Rammelkamp CH. Committee on Prevention of Rheumatic Fever and Bacterial Endocarditis, American Heart Association. Prevention of rheumatic fever and bacterial endocarditis through control of streptococcal infections. Circulation. 1955;11:317-320.
  • Habib G, Hoen B, Tornos P, Thuny F, Prendergast B, Vilacosta I, et al. Guidelines on the prevention, diagnosis, and treatment of infective endocarditis(new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology(ESC).Endorsed by the European Society of Clinical Microbiology and Infectious Diseases(ESCMID) and the International Society of Chemotherapy(ISC) for Infection and Cancer. Eur Heart J. 2009;30:2369-2413.
  • Habib G, Lancellotti P, Antunes MJ, Bongiorni MG, Casalta J-P, Del Zotti F, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36:3075-3128.
  • Wilson W, Taubert KA, Gewitz M, Lockhart PB, Baddour LM, Levison M, et al. Prevention of infective endocarditis: guidelines from the AHA: a guideline from the AHA Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. Circulation. 2007;116:1736-1754.
  • Richey R, Wray D, Stokes T. Prophylaxis against infective endocarditis: summary of NICE guidance. BMJ. 2008;336:770-771.
  • Lockhart PB, Blizzard J, Maslow AL, Brennan MT, Sasser H, Carew J. Drug cost implications for antibiotic prophylaxis for dental procedures. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013;115:345-353.
  • Keller K, von Bardeleben RS, Ostad MA, Hobohm L, Munzel T, Konstantinides S, et al. Temporal Trends in the Prevalence of Infective Endocarditis in Germany Between 2005 and 2014. Am J Cardiol. 2017;119:317-322.
  • Pant S, Patel NJ, Deshmukh A, Golwala H, Patel N, Badheka A, et al. Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011. J Am Coll Cardiol. 2015;65:2070-2076.
  • Dayer MJ, Jones S, Prendergast B, Baddour LM, Lockhart PB, Thornhill MH. Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis. Lancet Lond Engl. 2015;385:1219-1228.
  • Bin Abdulhak AA, Baddour LM, Erwin PJ, Hoen B, Chu VH, Mensah GA, et al. Global and regional burden of infective endocarditis, 1990-2010: a systematic review of the literature. Glob Heart. 2014;9:131-143.
  • Hoen B, Duval X. Clinical practice. Infective endocarditis. N Engl J Med. 2013;368:1425-1433.
  • Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler VG, Bayer AS, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med. 2009;169:463-473.
  • Şimşek-Yavuz S, Akar AR, Aydoğdu S, Berzeg Deniz D, Demir H, Hazırolan T, et al. Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report-2019. 2020;48:187-226.
  • Cahill TJ, Prendergast BD. Infective endocarditis. Lancet Lond Engl. 2016;387:882-893.
  • Nomura R, Naka S, Nemoto H, Inagaki S, Taniguchi K, Ooshima T, et al. Potential involvement of collagen-binding proteins of Streptococcus mutans in infective endocarditis. Oral Dis. 2013;19:387-393.
  • Barot H, Alsindi F. Endocarditis. Hosp Med Clin. 2017;6:229-243.
  • Serap Şimşek-Yavuz. İnfektif Endokardit: Güncel Bilgiler. Klimik J. 2015;28.
  • Bikdeli B, Wang Y, Kim N, Desai MM, Quagliarello V, Krumholz HM. Trends in hospitalization rates and outcomes of endocarditis among Medicare beneficiaries. J Am Coll Cardiol. 2013;62:2217-2226.
  • DeSimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, et al. Temporal trends in infective endocarditis epidemiology from 2007 to 2013 in Olmsted County, MN. Am Heart J. 2015;170:830-836.
  • Duval X, Delahaye F, Alla F, Tattevin P, Obadia J-F, Le Moing V, et al. Temporal trends in infective endocarditis in the context of prophylaxis guideline modifications: three successive population-based surveys. J Am Coll Cardiol. 2012;59:1968-1976.
  • Mackie AS, Liu W, Savu A, Marelli AJ, Kaul P. Infective Endocarditis Hospitalizations Before and After the 2007 American Heart Association Prophylaxis Guidelines. Can J Cardiol. 2016;32:942-948.
  • Toyoda N, Chikwe J, Itagaki S, Gelijns AC, Adams DH, Egorova NN. Trends in Infective Endocarditis in California and New York State, 1998-2013. JAMA. 2017;317:1652-1660.
  • van den Brink FS, Swaans MJ, Hoogendijk MG, Alipour A, Kelder JC, Jaarsma W, et al. Increased incidence of infective endocarditis after the 2009 European Society of Cardiology guideline update: a nationwide study in the Netherlands. Eur Heart J Qual Care Clin Outcomes. 2017;3:141-147.
  • Thornhill MH, Gibson TB, Cutler E, Dayer MJ, Chu VH, Lockhart PB, et al. Antibiotic Prophylaxis and Incidence of Endocarditis Before and After the 2007 AHA Recommendations. J Am Coll Cardiol. 2018;72:2443-2454.
  • Recommendations for research | Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures | Guidance | NICE. Available from: https://www.nice.org.uk/guidance/cg64/chapter/recommendations-for-research.
  • Sakai Bizmark R, Chang R-KR, Tsugawa Y, Zangwill KM, Kawachi I. Impact of AHA’s 2007 guideline change on incidence of infective endocarditis in infants and children. Am Heart J. 2017;189:110-119.
  • Pasquali SK, He X, Mohamad Z, McCrindle BW, Newburger JW, Li JS, et al. Trends in endocarditis hospitalizations at US children’s hospitals: impact of the 2007 American Heart Association Antibiotic Prophylaxis Guidelines. Am Heart J. 2012;163:894-899.
  • Bates KE, Hall M, Shah SS, Hill KD, Pasquali SK. Trends in infective endocarditis hospitalisations at United States children’s hospitals from 2003 to 2014: impact of the 2007 American Heart Association antibiotic prophylaxis guidelines. Cardiol Young. 2017;27:686-690.
  • DeSimone DC, Tleyjeh IM, Correa de Sa DD, Anavekar NS, Lahr BD, Sohail MR, et al. Incidence of Infective Endocarditis Due to Viridans Group Streptococci Before and After the 2007 American Heart Association’s Prevention Guidelines: An Extended Evaluation of the Olmsted County, Minnesota, Population and Nationwide Inpatient Sample. Mayo Clin Proc. 2015;90:874-881.
  • Seckeler MD, Hoke TR. The worldwide epidemiology of acute rheumatic fever and rheumatic heart disease. Clin Epidemiol. 2011;3:67-84.
  • Zegri-Reiriz I, de Alarcón A, Muñoz P, Martínez Sellés M, González-Ramallo V, Miro JM, et al. Infective Endocarditis in Patients With Bicuspid Aortic Valve or Mitral Valve Prolapse. J Am Coll Cardiol. 2018;71:2731-2740.
  • Dayer M, Thornhill M. Is antibiotic prophylaxis to prevent infective endocarditis worthwhile? J Infect Chemother Off J Jpn Soc Chemother. 2018;24:18-24.
  • Franklin M, Wailoo A, Dayer MJ, Jones S, Prendergast B, Baddour LM, et al. The cost-effectiveness of antibiotic prophylaxis for patients at risk of infective endocarditis. Circulation. 2016;134:1568-1578.
  • Guideline on Dental Management of Pediatric Patients Receiving Chemotherapy, Hematopoietic Cell Transplantation, and/or Radiation Therapy. Pediatr Dent. 2016;38:334-342.
  • Squire JD, Gardner PJ, Moutsopoulos NM, Leiding JW. Antibiotic Prophylaxis for Dental Treatment in Patients with Immunodeficiency. J Allergy Clin Immunol Pract. 2019;7:819-823.
  • Thornhill MH, Dayer M, Lockhart PB, Prendergast B. Antibiotic Prophylaxis of Infective Endocarditis. Curr Infect Dis Rep. 2017;19:9.
There are 39 citations in total.

Details

Primary Language English
Subjects Health Care Administration
Journal Section Review
Authors

Merve Candan 0000-0002-9839-871X

Publication Date February 24, 2021
Submission Date November 12, 2020
Published in Issue Year 2021Volume: 24 Issue: 1

Cite

EndNote Candan M (February 1, 2021) Infective Endocarditis Prophylaxis in Dentistry: Current Perspective. Cumhuriyet Dental Journal 24 1 96–104.
 Download Cover Image

Cumhuriyet Dental Journal (Cumhuriyet Dent J, CDJ) is the official publication of Cumhuriyet University Faculty of Dentistry. CDJ is an international journal dedicated to the latest advancement of dentistry. The aim of this journal is to provide a platform for scientists and academicians all over the world to promote, share, and discuss various new issues and developments in different areas of dentistry. First issue of the Journal of Cumhuriyet University Faculty of Dentistry was published in 1998. In 2010, journal's name was changed as Cumhuriyet Dental Journal. Journal’s publication language is English.


CDJ accepts articles in English. Submitting a paper to CDJ is free of charges. In addition, CDJ has not have article processing charges.

Frequency: Four times a year (March, June, September, and December)

IMPORTANT NOTICE

All users of Cumhuriyet Dental Journal should visit to their user's home page through the "https://dergipark.org.tr/tr/user" " or "https://dergipark.org.tr/en/user" links to update their incomplete information shown in blue or yellow warnings and update their e-mail addresses and information to the DergiPark system. Otherwise, the e-mails from the journal will not be seen or fall into the SPAM folder. Please fill in all missing part in the relevant field.

Please visit journal's AUTHOR GUIDELINE to see revised policy and submission rules to be held since 2020.